SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-003247
Filing Date
2023-03-09
Accepted
2023-03-09 07:01:03
Documents
84
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K elev-20221231x10k.htm   iXBRL 10-K 2087044
2 EX-10.10 elev-20221231xex10d10.htm EX-10.10 27096
3 EX-21.1 elev-20221231xex21d1.htm EX-21.1 3627
4 EX-23.1 elev-20221231xex23d1.htm EX-23.1 3497
5 EX-31 elev-20221231xex31.htm EX-31 14761
6 EX-32 elev-20221231xex32.htm EX-32 6551
7 GRAPHIC elev-20221231x10k001.jpg GRAPHIC 3735
8 GRAPHIC elev-20221231x10k002.jpg GRAPHIC 53909
9 GRAPHIC elev-20221231x10k003.jpg GRAPHIC 79145
  Complete submission text file 0001558370-23-003247.txt   7994522

Data Files

Seq Description Document Type Size
10 EX-101.SCH elev-20221231.xsd EX-101.SCH 49791
11 EX-101.CAL elev-20221231_cal.xml EX-101.CAL 48978
12 EX-101.DEF elev-20221231_def.xml EX-101.DEF 196613
13 EX-101.LAB elev-20221231_lab.xml EX-101.LAB 506419
14 EX-101.PRE elev-20221231_pre.xml EX-101.PRE 385459
78 EXTRACTED XBRL INSTANCE DOCUMENT elev-20221231x10k_htm.xml XML 1068243
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40523 | Film No.: 23718134
SIC: 2836 Biological Products, (No Diagnostic Substances)